Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 1383
TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319582(US10174007, Example 1 | US10787438, Example 1 | US...)
Affinity DataIC50: 1.5nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319605([(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-flu...)
Affinity DataIC50: 1.5nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319583(US10174007, Example 2 | US10787438, Example 2 | US...)
Affinity DataIC50: 1.5nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319602([(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1...)
Affinity DataIC50: 2.40nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319605([(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-flu...)
Affinity DataIC50: 2.60nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319582(US10174007, Example 1 | US10787438, Example 1 | US...)
Affinity DataIC50: 3.30nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319600([(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetid...)
Affinity DataIC50: 3.30nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319583(US10174007, Example 2 | US10787438, Example 2 | US...)
Affinity DataIC50: 3.60nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319601([(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)...)
Affinity DataIC50: 3.70nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319605([(1R,5S,6R)-3-{5-cyano-4-(1,1-difluoroethyl)-3-flu...)
Affinity DataIC50: 4.40nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319582(US10174007, Example 1 | US10787438, Example 1 | US...)
Affinity DataIC50: 5.5nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319583(US10174007, Example 2 | US10787438, Example 2 | US...)
Affinity DataIC50: 6.80nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319582(US10174007, Example 1 | US10787438, Example 1 | US...)
Affinity DataIC50: 7.30nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319603([(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)...)
Affinity DataIC50: 8nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319585(US10174007, Example 4 | US10787438, Example 4 | US...)
Affinity DataIC50: 8.40nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319602([(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1...)
Affinity DataIC50: 8.80nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319600([(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetid...)
Affinity DataIC50: 9.70nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319602([(1R,5S,6R)-3-{5-methyl-2-[(2S)-2-methylazetidin-1...)
Affinity DataIC50: 10.5nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319600([(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetid...)
Affinity DataIC50: 11nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319601([(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)...)
Affinity DataIC50: 11.1nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319600([(1R,5S,6R)-3-{2-[(2S,3R)-3-hydroxy-2-methylazetid...)
Affinity DataIC50: 12.1nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319586(US10174007, Example 5 | US10787438, Example 5 | US...)
Affinity DataIC50: 13.7nMAssay Description:Compounds having an IC50 value less than 20 nM were examined in a second KHK assay, referred to as Assay B, using 10-fold less enzyme and measuring a...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319585(US10174007, Example 4 | US10787438, Example 4 | US...)
Affinity DataIC50: 14.2nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319603([(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)...)
Affinity DataIC50: 17.8nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319586(US10174007, Example 5 | US10787438, Example 5 | US...)
Affinity DataIC50: 24.7nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319598(US10174007, Example 13 | US10787438, Example 13 | ...)
Affinity DataIC50: 33.9nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319585(US10174007, Example 4 | US10787438, Example 4 | US...)
Affinity DataIC50: 37.3nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319601([(1R,5S,6R)-3-{5-chloro-6-(difluoromethyl)-2-[(2S)...)
Affinity DataIC50: 37.9nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319603([(1R,5S,6R)-3-{6-(difluoromethyl)-5-methyl-2-[(2S)...)
Affinity DataIC50: 48.6nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319589(US10174007, Example 8 | US10787438, Example 8 | US...)
Affinity DataIC50: 53.8nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319586(US10174007, Example 5 | US10787438, Example 5 | US...)
Affinity DataIC50: 58.8nMAssay Description:A third KHK assay, referred to as Assay C, was performed at high fructose and ATP concentrations, conditions that would be more consistent with physi...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319585(US10174007, Example 4 | US10787438, Example 4 | US...)
Affinity DataIC50: 66nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319586(US10174007, Example 5 | US10787438, Example 5 | US...)
Affinity DataIC50: 95.5nMAssay Description:A fourth assay, referred to as Assay D, was performed using human KHK-A to assess the potency of compounds in inhibiting activity of this enzyme. Com...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319588(US10174007, Example 7 | US10787438, Example 7 | US...)
Affinity DataIC50: 111nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319587(US10174007, Example 6 | US10988463, Example 6 | US...)
Affinity DataIC50: 170nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319590(US10174007, Example 9 | US10787438, Example 9 | US...)
Affinity DataIC50: 188nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319584(US10174007, Example 3 | US10787438, Example 3 | US...)
Affinity DataIC50: 256nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319593(US10174007, Example 12 | US10787438, Example 12 | ...)
Affinity DataIC50: 289nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319591(US10174007, Example 10 | US10787438, Example 10 | ...)
Affinity DataIC50: 682nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetKetohexokinase(Human)
Pfizer

US Patent
LigandPNGBDBM319592(US10174007, Example 11 | US10787438, Example 11 | ...)
Affinity DataIC50: 866nMAssay Description:A 384-well format on a Corning 3653 assay plate is used, and monitored by UV-vis spectroscopy in continuous mode at rt. Compounds were prepared in DM...More data for this Ligand-Target Pair
In DepthDetails
US Patent